Literature DB >> 29399181

Downregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression.

Lei Zhang1, Lin Zhou1, Meng Shi1, Yong Kuang1, Lei Fang1.   

Abstract

Multiple myeloma (MM) is a malignant disorder characterized by the neoplastic growth of plasma cells in the bone marrow. MicroRNAs (miRNAs/miRs) modulate key regulatory cell pathways via their influence on target genes, and may serve a crucial function in tumorigenesis. Previous studies have indicated that the downregulation of miR-15a and miR-16 contributes to MM pathogenesis. However, the functional mechanisms of miR-15a and miR-16 in MM remain unclear. In the present study, potential target sites for miR-15a and miR-16 were identified on the calcineurin-binding protein 1 (CABIN1) mRNA sequence from analyses of previously published crosslinking, ligation and sequencing of hybrids data. Again-of-function study was also performed, which determined that miR-15a/16 directly targeted CABIN1 mRNA and negatively regulated the expression of CABIN1 at the mRNA and protein level in MM cells. A cell proliferation assay demonstrated that the upregulation of miR-15a and miR-16 inhibited the proliferation of MM cells via targeting CABIN1. miR-15a and miR-16 were significantly decreased in MM specimens, compared with in normal specimens, whereas CABIN1 mRNA levels were significantly higher in MM samples compared with in normal samples. CABIN1 mRNA levels were negatively correlated with miR-15a and miR-16 expression levels in MM tissues, as determined using Pearson's correlation coefficient analysis. The results of the present study indicate that the downregulation of miR-15a and miR-16 promotes tumor proliferation in MM by increasing CABIN1 expression. The present study may aid elucidation of the functions of miR-15a and miR-16 and their function in MM carcinogenesis.

Entities:  

Keywords:  calcineurin-binding protein-1; cell proliferation; microRNA-15a/16; multiple myeloma

Year:  2017        PMID: 29399181      PMCID: PMC5772676          DOI: 10.3892/ol.2017.7424

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  26 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Multiple myeloma.

Authors:  Antonio Palumbo; Kenneth Anderson
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

3.  Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.

Authors:  Roberta De Angelis; Pamela Minicozzi; Milena Sant; Luigino Dal Maso; David H Brewster; Gemma Osca-Gelis; Otto Visser; Marc Maynadié; Rafael Marcos-Gragera; Xavier Troussard; Dominic Agius; Paolo Roazzi; Elisabetta Meneghini; Alain Monnereau
Journal:  Eur J Cancer       Date:  2015-09-26       Impact factor: 9.162

4.  Thapsigargin-induced apoptosis involves Cabin1-MEF2-mediated induction of Nur77.

Authors:  W Liu; H D Youn; J O Liu
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

5.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

Authors:  Teru Hideshima; Constantine Mitsiades; Masaharu Akiyama; Toshiaki Hayashi; Dharminder Chauhan; Paul Richardson; Robert Schlossman; Klaus Podar; Nikhil C Munshi; Nicholas Mitsiades; Kenneth C Anderson
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

8.  Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding.

Authors:  Aleksandra Helwak; Grzegorz Kudla; Tatiana Dudnakova; David Tollervey
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

9.  Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma.

Authors:  Wei Kang; Joanna H M Tong; Raymond W M Lung; Yujuan Dong; Junhong Zhao; Qiaoyi Liang; Li Zhang; Yi Pan; Weiqin Yang; Jesse C S Pang; Alfred S L Cheng; Jun Yu; Ka Fai To
Journal:  Mol Cancer       Date:  2015-02-22       Impact factor: 27.401

10.  Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16.

Authors:  Yu-Tang Tung; Pin-Wu Huang; Yu-Ching Chou; Cheng-Wei Lai; Hsiu-Po Wang; Heng-Chien Ho; Chih-Ching Yen; Chih-Yen Tu; Tung-Chou Tsai; Dah-Cherng Yeh; Jiun-Long Wang; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Oncotarget       Date:  2015-04-30
View more
  12 in total

1.  Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.

Authors:  Yi Hu; Huimin Liu; Chuanfeng Fang; Chen Li; Fjorela Xhyliu; Hayley Dysert; Juraj Bodo; Gabriel Habermehl; Benjamin E Russell; Wenjun Li; Marcia Chappell; Xiaofeng Jiang; Sarah L Ondrejka; Eric D Hsi; Jaroslaw P Maciejewski; Qing Yi; Kenneth C Anderson; Nikhil C Munshi; Geyou Ao; Jason N Valent; Jianhong Lin; Jianjun Zhao
Journal:  Cancer Res       Date:  2020-03-19       Impact factor: 12.701

2.  Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma.

Authors:  Zhongqing Li; Lanting Liu; Chenxing Du; Zhen Yu; Yuanyuan Yang; Jie Xu; Xiaojing Wei; Fenghuang Zhan; Yongrong Lai; Lugui Qiu; Mu Hao
Journal:  Cancer Gene Ther       Date:  2020-01-28       Impact factor: 5.987

Review 3.  Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.

Authors:  Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

Review 4.  The Non-Coding RNA Landscape of Plasma Cell Dyscrasias.

Authors:  Eugenio Morelli; Annamaria Gullà; Roberta Rocca; Cinzia Federico; Lavinia Raimondi; Stefano Malvestiti; Valter Agosti; Marco Rossi; Giosuè Costa; Gianluca Giavaresi; Kareem A Azab; Antonia Cagnetta; Michele Cea; Pierosandro Tagliaferri; Antonino Neri; Nikhil C Munshi; Giuseppe Viglietto; Pierfrancesco Tassone; Nicola Amodio
Journal:  Cancers (Basel)       Date:  2020-01-30       Impact factor: 6.639

5.  MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis.

Authors:  Peipei Xu; Tian Xia; Yipeng Ling; Bing Chen
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis.

Authors:  Feifei Che; Jiao Chen; Chunqian Wan; Xiaobing Huang
Journal:  Front Oncol       Date:  2020-11-11       Impact factor: 6.244

7.  Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progression.

Authors:  Marta Chesi; Caleb K Stein; Victoria M Garbitt; Meaghen E Sharik; Yan W Asmann; Matteo Bergsagel; Daniel L Riggs; Seth J Welsh; Erin W Meermeier; Shaji K Kumar; Esteban Braggio; P Leif Bergsagel
Journal:  Blood Cancer Discov       Date:  2020-07

Review 8.  Small RNAs, Big Diseases.

Authors:  Iwona Rzeszutek; Aditi Singh
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

9.  MicroRNA‑4712‑5p promotes proliferation of the vulvar squamous cell carcinoma cell line A431 by targeting PTEN through the AKT/cyclin D1 signaling pathways.

Authors:  Shaojie Yang; Yanyan Zhao; Lufang Wang; Chang Liu; Ye Lu; Zhidong Fang; Hongshuang Shi; Wenyi Zhang; Xin Wu
Journal:  Oncol Rep       Date:  2019-09-17       Impact factor: 3.906

10.  LncRNA MORT Inhibits Cancer Cell Proliferation and Promotes Apoptosis in Mantle Cell Lymphoma by Upregulating miRNA-16.

Authors:  Xiaoqiong Tang; Yaoying Long; Liuyue Xu; Xinyu Yan
Journal:  Cancer Manag Res       Date:  2020-03-23       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.